LUSPATERCEPT
Tracking # 20-810989
$99999.00
There are no ratings for this course
Learn more Educator STATPEARLS PUBLISHING, LLC
CE Broker Reporting Reported automatically
Method Computer-Based Training
Course overview
LUSPATERCEPT IS A MEDICATION USED IN THE MANAGEMENT AND TREATMENT OF ANEMIA IN MYELODYSPLASTIC SYNDROMES, PRIMARY MYELOFIBROSIS, AND BETA-THALASSEMIA. IT IS A RECOMBINANT FUSION PROTEIN THAT BINDS TRANSFORMING GROWTH FACTOR-BETA LIGANDS TO REDUCE SMAD2 AND SMAD3 SIGNALING. THIS ACTIVITY DESCRIBES THE INDICATIONS, ACTIONS, AND CONTRAINDICATIONS FOR LUSPATERCEPT AS A VALUABLE AGENT IN THE MANAGEMENT WHEN APPLICABLE FOR MEMBERS OF THE INTERPROFESSIONAL TEAM.
Subject areas
This course counts toward the state boards and subject areas below.
Bahamas Medical Council
Specialty Medical Practitioner
1h
General Medicine
Louisiana State Board of Medical Examiners - Physicians & Surgeons
Physician & Surgeon
1h
Category I CME
Mississippi State Board of Medical Licensure
Medical Doctor
1h
AMA Category I
Physician Assistant
1h
AMA Category I
State Medical Board of Ohio
Doctor of Medicine
1h
AMA Category I